Monday, October 27, 2025
- 10:15AM-10:30AM
-
Abstract Number: 0874
Impact of Deucravacitinib on Disease Activity in Patients With Psoriatic Arthritis (PsA): Results From the Pivotal Phase 3 PsA Studies
Abstracts: Spondyloarthritis Including Psoriatic Arthritis – Treatment I: Therapies (0873–0878)- 10:15AM-10:30AM
-
Abstract Number: 0862
In immune-mediated necrotising myopathy, anti-HMGCR antibodies inhibit HMGCR activity, leading to the sarcoplasmic accumulation of lipid droplets and myofibres necrosis
Abstracts: Muscle Biology, Myositis & Myopathies – Basic & Clinical Science II: Basic & Translational Research (0861–0866)- 10:15AM-10:30AM
-
Abstract Number: 0856
Integrated Single-Cell and Spatial Transcriptomics Reveal Vascular and Immune Pathogenesis in APS Nephropathy
Abstracts: Antiphospholipid Syndrome (0855–0860)- 10:15AM-10:30AM
-
Abstract Number: 0892
Relapse and Immune Dysregulation in Giant Cell Arteritis Are Linked to Mosaic Loss of the Y Chromosome
Abstracts: Vasculitis – Non-ANCA-Associated & Related Disorders I: GCA From Bench to Bedside (0891–0896)- 10:30AM-12:30PM
-
Abstract Number: 1052
“Prednisone… A Necessary Evil…” Developing an Evidence-Based Benefits vs. Harms Shared Decision-Making Tool (PRED-SAFE) to Support Decisions Around Chronic Prednisone Use
(1038–1054) Health Services Research Poster II- 10:30AM-12:30PM
-
Abstract Number: 1375
86-96% of rheumatoid arthritis (RA) patients with RA who have 0 or 1 swollen joint or tender joint but are classified as moderate/high on RA indices have 1-9 comorbidities recognized on a multidimensional health assessment questionnaire (MDHAQ)
(1347–1375) Rheumatoid Arthritis – Treatment Poster II- 10:30AM-12:30PM
-
Abstract Number: 1287
A clear pattern of clinical presentation in juvenile systemic scleroderma is associated with interstitial lung disease
(1272–1305) Pediatric Rheumatology – Clinical Poster II- 10:30AM-12:30PM
-
Abstract Number: 1406
A Combined Score of Facet Joint Ankylosis and Syndesmophyte Development Correlates Well with Spinal Mobility in Axial Spondyloarthritis
(1405–1433) Spondyloarthritis Including Psoriatic Arthritis – Diagnosis, Manifestations, & Outcomes Poster II- 10:30AM-12:30PM
-
Abstract Number: 1405
A Combined Score of Syndesmophytes and Facet Joint Ankylosis Improves Sensitivity to Spinal Structural Damage Progression in Axial Spondyloarthritis
(1405–1433) Spondyloarthritis Including Psoriatic Arthritis – Diagnosis, Manifestations, & Outcomes Poster II- 10:30AM-12:30PM
-
Abstract Number: 1395
A Comparative Study of Yao Syndrome and Primary Sjögren’s Syndrome
(1376–1404) Sjögren’s Disease – Basic & Clinical Science Poster II: Clinical Manifestations and Health Outcomes- 10:30AM-12:30PM
-
Abstract Number: 1151
A Comparison of Patients with Cardiac Sarcoidosis vs. Other Systemic Manifestations of Sarcoidosis: A Retrospective Cohort Study
(1147–1190) Miscellaneous Rheumatic & Inflammatory Diseases Poster II- 10:30AM-12:30PM
-
Abstract Number: 1000
A Deep-Learning Based Approach Uncovers Novel Mediators of Micro-RNA Restraint of Type-2 Immunity
(0978–1006) T Cell Biology & Targets in Autoimmune & Inflammatory Disease Poster- 10:30AM-12:30PM
-
Abstract Number: 1626
A Delphi Exercise Informing the Development of Criteria to Measure Response to Treatment in Giant Cell Arteritis
(1612–1632) Vasculitis – Non-ANCA-Associated & Related Disorders Poster II- 10:30AM-12:30PM
-
Abstract Number: 0915
A fusion of TACI variant and anti-IFNAR antibody with greater therapeutic effect on related autoimmune disease models